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ABSTRACT
A retrospective analysis was performed to describe the cytomorphological and 
histopathological findings and human papillomavirus (HPV) genotypes for glassy cell 
carcinoma (GCC) of the uterine cervix. Five cases of cervical GCC, in which the glassy 
cell features constituted at least 95% of the specimen, were included. Four patients 
had stage IIB GCCs and one had stage IIIB GCC. All patients underwent concurrent 
chemoradiation therapy. Based on pretreatment cytology, only 1 of the 5 cases was 
correctly diagnosed as GCC. The remaining cases were diagnosed as carcinoma of 
undetermined type, adenocarcinoma, poorly differentiated carcinoma, or unsatisfactory 
for evaluation. Cytological specimens had moderate cellularity and contained small 
clusters of tumor cells admixed with amphophilic, granular tumor diathesis. The 
tumor cells possessed large, round to oval nuclei and abundant, granular, ground-
glass cytoplasm. The nuclei exhibited prominent eosinophilic nucleoli. The cytoplasm 
displayed sharp margins and molding, resulting in “intercellular windows” between 
neighboring attached cells. HPV genotyping revealed that high-risk HPV types 18, 16, 
and 31 were detected in 3, 1, and 1 cases, respectively. Consistent with this finding, all 
cases exhibited block p16 positivity, confirming the association of HPV infection with 
GCC. In conclusion, a distinct cytoplasmic margin, the characteristic histopathological 
feature of GCC, was observed in liquid-based cytological preparations. We suggest that 
sharp cytoplasmic outlines with molding and intercellular windows are characteristic 
cytomorphological features of GCC. Detection of high-risk HPV in all cases strongly 
supported the notion that high-risk HPV is involved in the pathogenesis of GCC.
INTRODUCTION
Glassy cell carcinoma (GCC) of the uterine cervix 
is a rare pathological form of cervical carcinoma that 
occurs in 1-2% of all cases [1–3]. The World Health 
Organization Classification currently considers this 
tumor to be a subtype of “other epithelial tumors” [4]. 
The mean patient age of those with GCC is ~10 years 
less than that of patients with squamous cell carcinoma 
or adenocarcinoma of the cervix [1, 2, 5]. GCC was 
first described by Cherry and Glucksmann [6] in 1956 
as a specific and distinctive entity of the most poorly 
differentiated adenosquamous carcinoma. They defined 
the histological diagnostic criteria and indicated that 
this tumor was uncommon and associated with poor 
prognosis. Two decades later, Littman et al. [2] described 
GCC tumors in detail, redefining and amplifying the 
histological criteria. Since then, interest in GCC has 
expanded and a number of studies have been conducted 
[1–3, 7–22]. However, cervical GCC is not yet widely 
recognized. Furthermore, because of GCC rarity there 
have been no clinical trials or large cohort studies.
Early detection of cervical cancer greatly increases 
the successful treatment rate. In countries with established 
early detection programs, the impact of cytology-based 
cervical screening is reflected in the substantial reduction 
in the cervical cancer incidence over the past 50 years 
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[23–27]. Although the aggressive clinical course of GCC 
encourages the use of early detection methods because 
data on the cytological features of GCC are limited, a 
cytological diagnosis can be difficult, despite characteristic 
histopathological features [1–4, 17]. Liquid-based 
cytology can improve specimen quality by providing a 
standardized method of collecting cervicovaginal material, 
and dispersing cells in a thin layer that is relatively 
inflammation-free [28–30]. This reduces the likelihood of 
unsatisfactory smears and increases the cytomorphological 
abnormality detection rate [31–37]. Although liquid-based 
cytology has become a common screening method for 
cervical cancer, limited information is available on the 
liquid-based cytology findings of GCC.
The aim of the present study was to describe the 
cytomorphological and histopathological features and 
immunophenotypes of cervical GCC. In addition, human 
papillomavirus (HPV) infection status in cervical GCCs 
was evaluated. We found characteristic cytomorphological 
features, and verified that those are consistent with typical 
histopathological features of GCC. We observed high-risk 
HPV infection and block p16 positivity in all examined 
cases.
RESULTS
Patient demographics
During the period from July 2007 to June 
2016, 675 patients were diagnosed as having primary 
cervical carcinoma. Thirty-three (4.9%) cases of 
poorly differentiated carcinoma were collected from 
computerized patient records. Based on the rarity of 
GCC, we reviewed the 9 (1.3%) cases of cervical poorly 
differentiated adenosquamous carcinoma. Among the 
9 cases, 2 cases that presented glassy cell features but 
that also had squamous (1 case) or glandular (1 case) 
differentiation, and 2 cases that had diffuse, strong p40 
expression were excluded. The remaining 5 (0.7%) cases 
were cervical GCCs. Five patients with cervical GCC 
were included in a retrospective analysis. The median and 
mean patients ages at diagnosis were 38 and 48.2 years, 
respectively (range, 36-67 years). Four (80.0%) of the 5 
patients had International Federation of Gynecology and 
Obstetrics (FIGO) stage IIB GCCs and the remaining 1 
(20.0%) had FIGO stage IIIB GCC. None of the patients 
were pregnant or had a recent history of pregnancy. All 
patients underwent concurrent chemoradiation therapy.
Cytological findings
The clinicopathological characteristics of the 5 
patients with cervical GCC are summarized in Table 1. 
Based on pretreatment cytology, only 1 (20.0%) of the 5 
cases was correctly diagnosed as GCC (case 4), although 
for the case with an unsatisfactory cytological specimen on 
the first examination, a cytological diagnosis of GCC was 
obtained from the recurrent tumor (case 3). The remaining 
cases were diagnosed as carcinoma, type undetermined 
(case 1), adenocarcinoma (case 2), or poorly differentiated 
carcinoma (case 5). There were no false negative results. 
Liquid-based cytology specimens displayed moderate 
cellularity and contained small clusters of polygonal 
tumor cells admixed with amphophilic, granular necrotic 
debris (tumor diathesis; Figure 1A). Most cellular clusters 
had < 20 cells. Even though most tumor cells were 
cohesive, individual tumor cells were frequently observed. 
A background of tumor diathesis was common (Figure 
1B). Some tumor cells assumed a pseudocolumnar shape, 
resembling endocervical cells (Figure 1C), but there was 
no definitive evidence of glandular differentiation. Rarely, 
cellular clusters showing vague acinar architecture and 
nuclear polarization were noted, but insufficient for 
diagnosis of adenocarcinoma. There was no evidence 
of dyskeratosis or intercellular bridge formation. The 
tumor cells possessed large, round to oval nuclei with a 
thin, irregular nuclear membrane. Although most tumor 
cells had finely dispersed chromatin, some had coarse 
chromatin and thick nuclear membranes with dense 
parachromatin. A moderate to large amount of tumor 
cell cytoplasm stained faintly blue with Papanicolaou 
stain, giving a fine ground-glass appearance (Figure 1D). 
The cytoplasm displayed distinct outlines with molding 
and clear, slit-like spaces between neighboring attached 
cells (“intercellular windows”; Figure 1E). The tumor 
cells were 3–7 fold larger than lymphocytes, and the 
majority of their nuclei contained prominent nucleoli 
(Figure 1F). Occasionally, tumor cell phagocytosis of 
apoptotic neutrophils was observed. There was a mixed 
population of inflammatory cells, mainly plasma cells 
and lymphocytes, in the background. Eosinophils, though 
present, were not easily detected. An intimate admixture of 
neutrophils and tumor cells, a so-called granuloepithelial 
complex [13], was often identified (Figures 1G-1I). 
Cytoplasmic molding and intercellular windows were 
often seen in these complexes. Frequent mitoses (Figures 
1J-1K) and atypical mitotic figures (Figures 1L) were 
detected.
Histopathological and immunohistochemical 
findings
Histopathologically, the tumor tissue consisted 
of nests, cords, or sheets of large polygonal cells with 
a moderate to large amount of pale, evenly spread, 
finely granular or ground glass-appearing cytoplasm 
(Figure 2A). The tumor cell nests were separated by 
thin, delicate fibrovascular septa, containing a cellular 
infiltrate, which consisted predominantly of plasma cells 
and lymphocytes admixed with eosinophils (Figure 2B). 
The individual tumor cells exhibited sharp cytoplasmic 
outlines and large, pleomorphic nuclei with prominent 
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nucleoli (Figure 2C). Mitotic figures were numerous 
and included abnormal forms (Figure 2D). Under high-
power magnification (×400), the distinct cytoplasmic 
margins that were seen on the cytological specimens 
were often observed. Cell shape variation associated 
with cytoplasmic molding and intercellular windows 
was consistent with that found on the cytology (Figures 
2E-2F). Some tumor cells displayed cytoplasmic 
microvacuolation. Bizarre multinucleated giant cells 
were commonly seen (Figure 2G). There was no 
evidence of squamous pearl formation, dyskeratosis, 
or intercellular bridge formation. Although a 
pseudocolumnar arrangement of the tumor cells that was 
observed on the cytological specimens was also found 
(Figure 2H), there was no evidence of gland formation or 
mucin production. A few microscopic foci of coagulative 
tumor cell necrosis were present.
Immunohistochemical staining results are shown in 
Table 1. Estrogen (ER; Figure 2I) and progesterone (PgR; 
Figure 2J) receptors were focally positive in 1 case. None 
of the cases showed p40 (Figure 2K) or carcinoembryonic 
antigen (CEA; Figure 2L) expression. In contrast, all cases 
exhibited diffuse and strong nuclear and cytoplasmic p16 
immunoreactivity (block positivity; Figure 2M).
HPV genotype status
HPV genotype was analyzed using HPV DNA 
chip assay. High-risk HPV was detected in all cases 
(Table 1). This result was in agreement with the block 
p16 positivity observed in all cases. The genotype was 
variable; type 18 was detected in three (60.0%) cases, 
and type 16 (20.0%) and type 31 (20.0%) was detected 
in 1 case for each. Multiple HPV genotypes were not 
observed.
DISCUSSION
It has been documented that GCC does not have 
a distinctive cytological appearance [2, 3, 17]. In the 
present study, a pretreatment cytological diagnosis of 
GCC was made in only 1 case examined. Similar to our 
observation, in a previous study, 1 of 9 (11.1%) GCC 
cases were correctly diagnosed on a cervicovaginal smear 
[13]. The remaining cases were diagnosed as squamous 
cell carcinoma (3 cases), adenocarcinoma (1 case), 
adenosquamous carcinoma (1 case), or carcinoma, 
unknown type (3 cases). The reason for such a low 
diagnostic accuracy in cytology might be attributed to 
the lack of differentiation and a low suspicion index 
for GCC. However, pathologists should be aware of the 
cytomorphological features of GCC because it not only 
has relatively unique cytomorphology but also diagnostic 
pitfalls, leading to occasional misdiagnosis. In our series, 
the established histopathological findings of GCC were 
verified in the cytological specimens. Clusters of tumor 
cells with abundant, granular cytoplasm, pleomorphic 
nuclei, and prominent nucleoli were consistent with GCC 
histomorphology. In addition, sharp cytoplasmic outlines 
of GCC cells associated with cytoplasmic molding 
Table 1: Results of cytology, biopsy, immunostaining, and HPV genotyping and treatment of cervical GCC
Case Age FIGO 
stage
Cytology result Biopsy 
result
Immunostaining result HPV 
genotype
Treatment
p40 CEA ER PgR p16
1 38 IIB Carcinoma, type 
undetermined
GCC Negative Negative Negative Negative Block
positive
HR HPV 
(type 18) 
detected
CCRT
2 63 IIB Adenocarcinoma GCC Negative Negative Negative Negative Block 
positive
HR HPV 
(type 16) 
detected
CCRT
3 36 IIB Unsatisfactory/
GCC*
GCC Negative Negative Negative Negative Block 
positive
HR HPV 
(type 31) 
detected
CCRT
4 67 IIIB GCC GCC Negative Negative Negative Negative Block 
positive
HR HPV 
(type 18) 
detected
CCRT
5 37 IIB Poorly 
differentiated 
carcinoma
GCC Negative Negative Focal 
positive
Focal 
positive
Block 
positive
HR HPV 
(type 18) 
detected
CCRT
Abbreviations: CCRT: concurrent chemoradiation therapy, CEA: carcinoembryonic antigen, ER: estrogen receptor; FIGO: 
International Federation of Gynecology and Obstetrics, GCC: glassy cell carcinoma, HPV: human papillomavirus, HR: 
high-risk, PgR: progesterone receptor; *At the time of recurrence
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and intercellular window formation were apparent in 
liquid-based cytological preparations, and these were 
confirmed on histopathological examination. Although 
sharp cytoplasmic margins have been suggested as a 
histopathological characteristic of GCC, there have 
been no reports concerning cytoplasmic molding and 
intercellular windows as cytomorphological features. 
Since these 2 features are typically found in reactive or 
Figure 1: Liquid-based cytological findings of cervical glassy cell carcinoma. A. Thinprep preparation of the cervical sample 
shows amphophilic, granular necrotic debris (tumor diathesis) and a few small clusters of polygonal tumor cells. B. The tumor cell 
clusters or individually scattered tumor cells are unevenly distributed. Tumor diathesis is apparent. C. Although some tumor cells display 
endocervical-like pseudocolumnar arrangements (black arrowheads), there is no definite evidence of glandular differentiation. A white 
arrow indicates the intercellular window. D. The tumor cells have relatively fine chromatin and prominent, solitary nucleoli. Abundant, 
cyanophilic cytoplasm and discrete cell borders (white arrows) are evident. E. Under high-power magnification (×400), the tumor cells 
show large, oval to round, pleomorphic nuclei and “intercellular windows” produced by discrete cytoplasmic outlines and cytoplasmic 
molding (white arrow). There are no intercellular bridges. F. Tumor cells are 3–7 fold larger than lymphocytes or neutrophils. Chromatin 
distribution irregularities, hyperchromasia, and significant anisonucleosis are apparent. G-I. In several areas, an intimate admixture of 
neutrophils (red circles) and tumor cells, so-called granuloepithelial complexes, is seen. Cytoplasmic molding and intercellular windows 
(white arrows) are observed. J-K. Mitotic figures (blue arrows) are present. L. Atypical mitotic figures (red arrow) are also detected (A-L, 
Papanicolaou stain).
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neoplastic mesothelial lesions, it is difficult to conclude 
that they are pathognomonic for cervical GCC. However, 
because cytoplasmic molding and intercellular windows 
are not found in liquid-based cytology of common 
cervical neoplastic lesions such as high-grade squamous 
intraepithelial lesion, squamous cell carcinoma, 
adenocarcinoma in situ, and endocervical adenocarcinoma, 
it could be inferred that at least cytoplasmic molding and 
Figure 2: Histopathological and immunohistochemical findings of cervical glassy cell carcinoma. A. Glassy cell carcinoma 
consists of tumor cell nests with pale to eosinophilic, abundant cytoplasm. Mitotic figures are frequently observed (blue arrow). B. The 
tumor cell nests are surrounded by thin fibrovascular connective tissue septa with lymphoplasmacytic infiltrate. A blue arrow indicates 
a mitotic figure within the tumor cell. C. The individual tumor cells display large nuclei with single, prominent nucleoli. D. Tumor cell 
cytoplasm possesses eosinophilic, granular cytoplasm, and some exhibit variable-sized microvacuoles. In several areas, mitotic figures are 
frequent (blue arrow), including abnormal forms (red arrows). E. The tumor cells show distinct cytoplasmic margins and “intercellular 
windows” (white arrows), which are also apparent in cytological specimens. F. Under high-power magnification (×400), cytoplasmic 
molding and clear, slit-like intercellular spaces (white arrows) are obviously observed, but intercellular bridging is absent. G. Some bizarre 
multinucleated giant cells are noted. H. Although cells with a pseudocolumnar arrangement can be seen (black arrowheads), there is 
no definite evidence of gland formation. I-M. Immunohistochemically, some tumor cells are positive for (I) estrogen receptor and (J) 
progesterone receptor in a single case. None of the cases examined shows immunoreactivity for (K) p40 or (L) carcinoembryonic antigen. 
In contrast, all cases exhibited block positivity for (M) p16 (A-H, hematoxylin and eosin stain; I-M, polymer method).
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distinct intercellular windows could be useful cytological 
features to diagnose GCC.
Previous studies have found a strong association 
between cervical GCC and high-risk HPV infection [3, 
7–12], which would be consistent with the findings in the 
present study. According to an accumulation of the present 
and previous data, the overall prevalence of high-risk HPV 
infection would be 51.3% (20/39; Table 2). Interestingly, 
3 previous cases showed multiple high- and low-risk HPV 
infections [12], whereas in the present study high-risk 
HPV alone was noted. In the present study, 3 (60.0%) 
cases had HPV type 18, which was the most common type 
detected in previous studies (10/15; 75.0%). HPV type 18 
is most commonly associated with glandular tumors of the 
uterine cervix [4, 7, 8], which leads to the argument that 
GCC should be identified as a subtype of adenocarcinoma 
rather than of squamous cell carcinoma; however, the 
GCC glandular lineage cannot be proven because HPV 
type 18 is not specific to glandular lesions. In fact, HPV 
type 18 is the second most common HPV types in cervical 
squamous epithelial lesions and is strongly associated with 
high-grade neuroendocrine carcinomas [38]. Therefore, it 
is reasonable to assume that HPV type 18 has an ability 
to make a target cell differentiate in variable directions 
[8]. Although the pathogenetic importance of high-risk 
HPV infection in cervical GCC could not be determined 
definitively because of the small number of cases reported, 
based on the results of the present and previous studies 
there is a high possibility that it is involved in GCC 
carcinogenesis. Further studies are needed for a full 
evaluation of HPV infection status in GCC of the uterine 
cervix.
In the present study, all the five cases we examined 
expressed block p16 positivity, which was consistent with 
the presence of high-risk HPV. In addition, focal ER and 
PgR positivity in 1 case was consistent with a previous 
study that detected ER (2 cases) and PgR (1 case) among 
11 cases of GCC [16]. However, considering that the 
remaining 4 cases were negative for both ER and PgR, and 
most cervical carcinomas does not express these hormone 
receptors, their expression may be unusual in GCC.
Cytological differential diagnoses of cervical 
GCC include atypical reparative cells, nonkeratinizing 
squamous cell carcinoma with severe inflammation, 
lymphoepithelioma-like carcinoma, and malignant 
melanoma. Pak et al. [17] reported a false-negative 
rate of 33% when performing a cytological diagnosis 
of GCC. In GCC, frequently appearing syncytial 
tumor cell arrangements and abundant cytoplasm may 
deceive cytopathologists. In typical repair, cells occur 
primarily in monolayer sheets and syncytia and contain 
prominent nucleoli. However, nuclear piling, significant 
Table 2: Previously reported HPV prevalence rate and genotypes in cervical GCC
Year
published
Author HPV 
prevalence rate
HPV genotype
Category Type (number of case) Detection 
method
1998 Kenny et al. [7] 27.8% (5/18) HR 18 (4), 16 (1) ISH
2002 Kato et al. [8] 66.7% (2/3) HR 18 (2) PCR
2004 Hirai et al. [9] 100.0% (2/2) HR 18 (2) PCR
2004 Ng et al. [10] 0.0% (0/1) Not detected PCR-RFLP
2004 Matthews-Greer et al. 
[11]
100.0% (1/1) HR 16 (1) PCR
2009 Kim et al. [12] 55.6% (5/9) HR and LR 18 (2), 31+32 (1),
35+68+32 (1), 39+6 (1)
DNA chip
2016 Jung et al.* 100.0% (5/5) HR 18 (3), 16 (1), 31 (1) DNA chip
1998-2016 Total 51.3% (20/39) HR 18 (65.0%; 13/20),
16 (15.0%; 3/20),
31 (10.0%; 2/20),
35 (5.0%; 1/20),
39 (5.0%; 1/20),
68 (5.0%; 1/20)
LR 32 (10.0%; 2/20),
6 (5.0%; 1/20)
Abbreviations: HPV: human papillomavirus, HR: high-risk, ISH: in situ hybridization, LR: low-risk, PCR: polymerase 
chain reaction, PCR-RFLP: polymerase chain reaction-restriction fragment length pleomorphism assay; *The present study
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anisonucleosis, and irregularities in chromatin distribution 
that exceed changes in typical repair, can result in the 
false exclusion of carcinoma. Nevertheless, atypical 
reparative reactions lack both tumor diathesis and nuclear 
hyperchromasia. Moreover, isolated atypical tumor cells 
in reparative reactions are uncommon [13]. Compared 
with nonkeratinizing squamous cell carcinoma with 
inflammation, GCC tumor cells are larger and more 
polygonal with larger nuclei and distinct cell membranes. 
Nonkeratinizing squamous cell carcinoma has more oval 
nuclei with coarser chromatin, which is frequent distributed 
along the nuclear membrane. In lymphoepithelial-like 
carcinoma, cell membranes are indistinct, and the nuclear 
chromatin is distributed peripherally, marginating the 
nuclear membrane. Although eosinophils are often 
observed in GCC, in lymphoepithelial-like carcinoma the 
majority of infiltrating inflammatory cells are lymphocytes 
and plasma cells, which might be useful for differentiation. 
However, it is not clear if there is a significant difference 
in proportion of the inflammatory cells between these 2 
diseases because in the present cases, lymphoplasmacytic 
infiltrates were dominant. A misdiagnosis of malignant 
melanoma might be avoided by the absence of cytoplasmic 
melanin pigments and epithelial marker immunoreactivity. 
GCC neither expresses HMB-45 nor Melan A.
In conclusion, we have described the cytomorphology, 
histopathology, immunophenotype, and HPV genotypes of 
cervical GCC. We demonstrated that distinct cytoplasmic 
margins are a major cytomorphological and histopathological 
feature of GCC. Cytoplasmic molding and intercellular 
window formation might be useful cytomorphological 
characteristics for a differential diagnosis of GCC, especially 
in liquid-based preparations. In addition, high-risk HPV 
infection in all cases supported the notion that high-risk HPV 
is involved in the pathogenesis of GCC.
MATERIALS AND METHODS
Case selection
Glassy cell features were defined based on the 3 main 
criteria originally reported by Cherry and Glucksmann [6] and 
amplified by Littman et al. [2] as: (1) cells with a moderate 
amount of ground-glass or finely granular cytoplasm that 
stains faintly blue with hematoxylin and eosin, (2) distinct 
cytoplasmic borders that stain with eosin and periodic acid-
Schiff, and (3) large nuclei with conspicuous nucleoli. The 
present study was restricted to cases in which the glassy 
cell features constituted at least 95% of the specimen. All 
available slides of 9 poorly differentiated adenosquamous 
carcinoma cases were reviewed. Five cases of cervical GCCs 
were included in the present study. Pretreatment cytological 
specimens were available for all 5 cases. The present study 
was reviewed and approved by the Institutional Review 
Board of Severance Hospital, Yonsei University Health 
System, Seoul, Republic of Korea (2016-1010-001).
Liquid-based cytological specimen preparation
For liquid-based cytological smears, samples 
were taken from the fornix, portio, and endocervix. 
The ThinPrep test (Hologic Inc., Marlborough, MA, 
USA) was performed using an automated liquid-based 
monolayer cell preparation system (ThinPrep 2000 
system; Hologic Inc.), according to manufacturer’s 
recommendations. Briefly, the samples were immersed 
in CytoLyt buffer (Hologic Inc.) and then transferred to 
a PreservCyt bowl (Hologic Inc.). Cells were released 
by pushing the brush to the bottom, forcing the bristles 
apart, and swirling the brush in the fluid. A cylinder 
containing a filtration membrane was placed in the bowl 
and rotated to ensure homogeneous cell distribution. 
Erythrocytes and mucus were allowed to penetrate the 
filtration membrane under negative pressure, leaving 
the cell membranes on the filtration membrane. Each 
ThinPrep slide was fixed in ethanol and stained using 
the Papanicolaou method. Tumor diathesis, cellular 
composition, and cellular arrangement of the specimens 
were evaluated.
Histopathological examination
The biopsied specimens were fixed in 10% neutral-
buffered formalin and embedded in paraffin blocks. From 
each formalin-fixed, paraffin-embedded block, 4-μm 
sections were cut and stained with hematoxylin and eosin. 
A variable number of hematoxylin and eosin-stained slides 
from each case were available for review. Among these, 
the most representative slide, containing an appropriate 
volume of tumor and possibly normal cervical tissue, 
was chosen for immunohistochemical staining and HPV 
genotyping.
Immunohistochemistry
The formalin-fixed, paraffin-embedded sections 
were deparaffinized and rehydrated using xylene and 
alcohol. Immunohistochemical staining was performed 
using the Ventana Benchmark XT automated staining 
system (Ventana Medical Systems, Tucson, AZ, USA) 
or the Dako Omnis (Dako, Agilent Technologies, 
Carpinteria, CA, USA), according to the manufacturer’s 
instructions. Antigen retrieval was performed using Cell 
Conditioning Solution (CC1; Ventana Medical Systems) 
or EnVision FLEX Target Retrieval Solution, High pH 
(Dako, Agilent Technologies). Sections were incubated 
with primary antibodies (Table 3). After chromogenic 
visualization, using ultraView Universal DAB Detection 
Kits (Ventana Medical Systems) or EnVision FLEX /HRP 
(Dako, Agilent Technologies), slides were counterstained 
with hematoxylin. Appropriate positive and negative 
controls were stained concurrently to validate the 
staining method.
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Human papillomavirus genotyping
We performed polymerase chain reaction 
(PCR)-based microarray for HPV genotyping, using a 
commercially available HPV 9G DNA chip (BMT HPV 
9G DNA Chip; Biometrix Technology, Chuncheon, 
Republic of Korea) [39]. The 9G test examined the 
presence of 14 high-risk (16, 18, 31, 33, 35, 39, 45, 51, 
52, 56, 58, 59, 66, 68) and 5 low-risk (6, 11, 34, 40, 
42) HPV types; analyses were performed according to 
the manufacturer’s instructions [40]. Briefly, the PCR 
mixture consisted of 10 μL of the extracted target DNA, 
10 μL of the primer set (provided by the manufacturer), 
and PCR premix (provided by the manufacturer), 
which contained dNTP and Taq DNA polymerase in 
an amplification buffer. Amplification was performed 
using the following steps: predenaturation for 5 min at 
94°C; 40, 30-s denaturation cycles at 94°C; 40, 30-s 
annealing cycles at 45°C; 40, 30-s elongation cycles at 
72°C; and a final 5-min elongation step at 72°C. PCR 
products were electrophoresed in a 2% agarose gel to 
confirm successful amplification. Each hybridization 
chamber of the 9G was covered with a mixture of the 
hybridization solution (35 μL) and PCR product (15 
μL), followed by incubation at 23–26°C for 30 min. 
After washing, array images were scanned and imaged 
using a fluorescent scanner (ScanArray GX Microarray 
Scanner, PerkinElmer Life and Analytical Sciences, 
Waltham, MA, USA).
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